The pathophysiology and treatment of rheumatoid arthritis - PubMed (original) (raw)

Review

The pathophysiology and treatment of rheumatoid arthritis

W P Arend. Arthritis Rheum. 1997 Apr.

No abstract available

PubMed Disclaimer

Similar articles

• Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies.
  Kingsley G, Pitzalis C, Panayi GS. Kingsley G, et al. Br J Rheumatol. 1990 Feb;29(1):58-64. doi: 10.1093/rheumatology/29.1.58. Br J Rheumatol. 1990. PMID: 2407306 Review. No abstract available.
• Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis.
  Mateen S, Zafar A, Moin S, Khan AQ, Zubair S. Mateen S, et al. Clin Chim Acta. 2016 Apr 1;455:161-71. doi: 10.1016/j.cca.2016.02.010. Epub 2016 Feb 13. Clin Chim Acta. 2016. PMID: 26883280 Review.
• T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices?
  Kinne RW, Palombo-Kinne E, Emmrich F. Kinne RW, et al. Biochim Biophys Acta. 1997 Apr 12;1360(2):109-41. doi: 10.1016/s0925-4439(96)00079-8. Biochim Biophys Acta. 1997. PMID: 9128178 Review. No abstract available.
• Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
  Maini RN, Taylor PC, Paleolog E, Charles P, Ballara S, Brennan FM, Feldmann M. Maini RN, et al. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I56-60. doi: 10.1136/ard.58.2008.i56. Ann Rheum Dis. 1999. PMID: 10577974 Free PMC article. Review. No abstract available.

Cited by

• Estimating the prevalence and predictors of musculoskeletal disorders in Tanzania: a cross-sectional pilot study.
  Yongolo NM, Halliday J, Bunn C, Mtesha B, Kelly C, Krauth SJ, Mwingwa A, Biswaro SM, Siebert S, Kipengele AH, Walker RW, McIntosh E, Mmbaga BT. Yongolo NM, et al. Pan Afr Med J. 2024 Jan 30;47:36. doi: 10.11604/pamj.2024.47.36.38258. eCollection 2024. Pan Afr Med J. 2024. PMID: 38586069 Free PMC article.
• Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet's dısease.
  Ellergezen P, Coşkun BN, Çeçen GS, Bozkurt ZY, Ağca H, Dalkılıç HE, Çavun S. Ellergezen P, et al. Clin Exp Med. 2023 Dec;23(8):5345-5353. doi: 10.1007/s10238-023-01173-3. Epub 2023 Sep 20. Clin Exp Med. 2023. PMID: 37728818
• The effect of immunomodulatory properties of naringenin on the inhibition of inflammation and oxidative stress in autoimmune disease models: a systematic review and meta-analysis of preclinical evidence.
  Alimohammadi M, Mohammad RN, Rahimi A, Faramarzi F, Alizadeh-Navaei R, Rafiei A. Alimohammadi M, et al. Inflamm Res. 2022 Nov;71(10-11):1127-1142. doi: 10.1007/s00011-022-01599-7. Epub 2022 Jul 8. Inflamm Res. 2022. PMID: 35804246 Review.
• The P2X7 receptor (P2X7R)-specific antagonist A804598 inhibits inflammatory reaction in human fibroblast-like synoviocytes.
  Liu Y, Wu Y, Gu S, Yin Q, Li H, Wang J, Geng D, Xu Y. Liu Y, et al. Am J Transl Res. 2020 Jan 15;12(1):45-53. eCollection 2020. Am J Transl Res. 2020. PMID: 32051736 Free PMC article.
• Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis.
  Usenbo A, Kramer V, Young T, Musekiwa A. Usenbo A, et al. PLoS One. 2015 Aug 4;10(8):e0133858. doi: 10.1371/journal.pone.0133858. eCollection 2015. PLoS One. 2015. PMID: 26241756 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information